1
|
Berens-Riha N, De Block T, Rutgers J, Michiels J, Van Gestel L, Hens M, Kenyon C, Bottieau E, Soentjens P, van Griensven J, Brosius I, Ariën KK, Van Esbroeck M, Rezende AM, Vercauteren K, Liesenborghs L. Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022. Euro Surveill 2022; 27:2200894. [PMID: 36695462 PMCID: PMC9716643 DOI: 10.2807/1560-7917.es.2022.27.48.2200894] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
Abstract
Vaccination is important in containing the 2022 mpox (formerly monkeypox) epidemic. We describe five Belgian patients with localised severe symptoms of proctitis and penile oedema, occurring between 4 and 35 days after post-exposure preventive vaccination or after one- or two-dose off-label pre-exposure preventive vaccination with MVA-BN vaccine. Genome sequencing did not reveal evidence for immune escape variants. Healthcare workers and those at risk should be aware of possible infections occurring shortly after vaccination and the need for other preventive measures.
Collapse
Affiliation(s)
| | | | | | | | | | - Matilde Hens
- Institute of Tropical Medicine, Antwerp, Belgium
| | | | - Chris Kenyon
- Institute of Tropical Medicine, Antwerp, Belgium,University of Cape Town, Cape Town, South Africa
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|